Earnings call transcript: CytoSorbents Q1 2026 misses forecasts, stock falls

Integrity note  ·  Xela does not rewrite or paraphrase article content. The excerpt above is the source publication's own words, sanitized for display. For the full piece — including any quotes, charts, or images — read it at Investing.com. Xela's rewritten version is off for this story, so there's no editorial angle attached — you're getting the source's reporting unfiltered. When the rewrite is on, we add a What this means block underneath with the operator/trader takeaway.